← Evidence map

ArticleFrontiers in immunology2023

A meaningful exploration of ofatumumab in refractory NMOSD: a case report.

Yibo Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37449206